Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Justa & Lars Honors Bob Brinker Investment Club -- Ignore unavailable to you. Want to Upgrade?

To: marc ultra who wrote (10336)	12/9/1999 11:53:00 PM
From: marc ultra	Read Replies (1) \| Respond to of 15132

OT:one of the two small biotechs I have and mentioned the other day was ENMD. Was up 32% today on no news. Currently has Phase 1 trials on the drug endostatin going on at three centers. This is the human version of endostatin. You may recall the mouse experiments which led to a front page article in the NYT in 4/98 with the news blasted around the world about mice tumors shrinking to nothing with no resistance on retreatment. It's a little early to expect some leak on early results to cause this and some was short covering and maybe day traders jumping in but this angiogenesis inhibitor drug could prove very powerful. Will have to see. Note this is not a recommendation to purchase. Marc